Ignite Creation Date:
2025-12-24 @ 4:02 PM
Ignite Modification Date:
2026-03-16 @ 6:51 PM
Study NCT ID:
NCT06889766
Status:
RECRUITING
Last Update Posted:
2025-04-20
First Post:
2025-03-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma
Sponsor:
Centre Hospitalier Universitaire Vaudois
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CHUV-DO-0026-NYESO1-2023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None